A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...
A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted treatments with fewer “awful” side effects.
Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.
Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...
The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...
Lain Blevins was diagnosed with a rare form of bone cancer after experiencing leg pain, which he and his family put down to ...
British professor Paul Workman has announced a major breakthrough for rare and untreatable bone cancer chordoma.
Citing a recent LANCET study, he underlined that "timely cancer treatment initiation has improved significantly because of ...
Leighland Reddin, from Morley, West Yorkshire, started complaining of head pain and stopped eating or drinking in November ...
At 16 years old, Tia Bee Stokes opened a letter that would change her future, telling her that in 10 to 15 years, she would ...
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results